chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swelling on  the face ( eyes and mouth) the next morning after getting the injection as well as rash all over the body  to combat the reaction the patient took 2 benadryls.
4/30 PM vaccine. Awoke AM 5/2 with discomfort at vaccine site (mild), noted moderate soft tissue swelling and erythema surrounding injection site.
48 hours post vax, the pt experienced swelling, warmth, redness, and inflammation from injection site at top of deltoid of right arm down to elbow from outside of arm around to behind right arm.
Terrible pressure headache the day of both shots.   Then 30 days after my second dose of Moderna, I developed Optic Neuritis and lost my vision completely in my right eye in a matter of 3 days. After many ER visits, MRIs, an LP, a central line placed in my neck while not sedated, 9 days in the hospital, and 5 plasma exchanges, they determined I was perfectly healthy and they couldn?t find a reason why I got it. No signs of autoimmune diseases, and I was clear of all other tests. I was able to regain vision thanks to the multiple plasma exchanges and the quick acting doctors. I could have lost my vision permanently if I wasn?t treated right away. I?m concerned that this was the vaccine because the doctors couldn?t find any other reason why this would happen.  I also don?t have anyone in my family with any history of neurological disorders or diseases.
Unilateral neuropathy in peroneal area; Did not want to provide addtl details; no other info expected;
This case was reported by a nurse via call center representative and described the occurrence of adverse reaction in a adult patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown. It was unknown if the reporter considered the adverse reaction to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The Medical Practitioner called in and stated that, she might have a potential adverse event with the SHINGRIX vaccine. No information was provided by the nurse, due to them calling on behalf of the patient. Attempt to warm transfer the nurse to the line and received a voicemail that, the users voicemail was full and the nurse was disconnected.
Mild rash at injection site and on same arm, with some spots on the rest of the body.  Mild rash on the face on Friday, 3-12-2021.  Rash not present immediately after vaccine, nor during the wait-time of 15 minutes after the shot.  I felt achy and tired that same evening after receiving the injection, but did not experience the rash until a few days later.
7-8 hours after receiving vaccine, had fatigue, nausea that resolved within a few hour.  Later that night had nightsweats but no documented fever.  Also 7-8 hour after receiving vaccine had acute onset vertigo and then hand and feet numbness, tingling, weakness.  Occurred intermittently over the next 48 hours and gradually resolved. Had hives about 7-8 hours after vaccine but was within 20 min of eating and pt has known allergic reactions to some foods (undergoing allergy eval currently).  Hives immediately resolved with Benadryl and did not recur.  No evaluations/testing done.  No treatment sought.  All sx self-resolved.
Developed a hyperactive thyroid.  Lost weight (25 lbs), sleep loss, shaking, irritable, etc.  Dx, Graves Disease.
Information has been received from a physician assistant concerning a "teenager" female who was vaccinated with GARDASIL 0.5 ml. After getting GARDASIL the patient experienced depression. At the time of reporting, the outcome was not reported. The patient sought unspecified medical attention. No further information is available.
Erythema multiform, resolved. Seen allergiist. Allergist referred diagnosed.
This infant had redness with erythema of the site, and a whole body rash. The patient became extremely irritable, inconsolable for several hours, and a fever. It took two days for the patient to return to normal.
Felt like the flu. By evening I was in bed with high fever (102+), body aches, chills, stomach discomfort, dizziness, weakness
Excessive urination and thirst from the night of my shot. severe vision change. A1C went to 13.4 from 7.1 that was taken 8/2022. 20 pound weight loss.  symptoms let up about 8 weeks from onset.  currently on Ozempic .25 once a week since 1/1/2023 which has helped lower 1C to 9.4 as of 2/10/2023
10/22/09 8AM Red splotches all over face. Hot to touch all over face. Starting at eark and worked it's way around face. MD noticed child started on 1/4 tsp ZYRTEC 5:30PM. Hot to touch went away, splotches not as red. This an hot touch splotches more red and looks like more all over face. Mother will call MD.
Information was received on 01-AUG-2017 from a lawyer regarding a case in litigation concerning a male patient of unknown age.  Medical history, concurrent conditions, and concomitant medications were not provided. It was reported that the patient was vaccinated with a dose of ZOSTAVAX (lot number, dosage, and route of administration not provided) on or about 08-SEP-2013 at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 02-JAN-2014, the patient was treated by a physician for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles with post herpetic neuralgia, a chronic condition of residual nerve pain and damage secondary to shingles. The patient has experience significant pain and complications from his shingles infections, which have spread to his eyes, scalp and face. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result the patient has suffered and will continue to suffer significant medical expenses, pain and suffering and other damages. Additional information has been requested.
Hospitalized with Pulmonary Thrombosis in both lungs. This occurred approximately 3 weeks after second injection. I had difficulty   breathing so admitted myself to Hospital
Arm pain after 2 hours, fatigue after 9 hours, headache after 8.5 hours, fever/chills after 13-14 hours, nausea/vomiting after 15.5 hours, muscle aches sometime during the night or in the morning.
Second dose was not applied in the correct interval; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Second dose was not applied in the correct interval) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Second dose was not applied in the correct interval). On 18-Mar-2021, PRODUCT DOSE OMISSION ISSUE (Second dose was not applied in the correct interval) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medication reported   No treatment medication reported
Reportedly 48 hours post vax, the pt developed a warm, red, painful area at the injection site. Follow up data received 10/05/2000 states no further information is anticipated for this report. Case is closed.
soreness of the affect arm at the site of the vaccination; Fatigue; body aches; This is a spontaneous report from a contactable Nurse. A female patient (reporter's sister) of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number was not reported), dose 1 via an unspecified route of administration on 18Feb2021 at 07:45 A.M as DOSE 1, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient experienced soreness of the affect arm at the site of the vaccination, fatigue, and body aches. The clinical outcome for the events was unknown.  Follow-up attempts are completed. No further information is expected.
Poison ivy and a rash in the crease between my belly and right hip; Poison ivy; This case was reported by a consumer via interactive digital media and described the occurrence of rash in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 12th March 2022, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced rash and poison ivy rash. The patient was treated with prednisone. On an unknown date, the outcome of the rash was unknown and the outcome of the poison ivy rash was not recovered/not resolved.   It was unknown if the reporter considered the rash and poison ivy rash to be related to Shingrix.     Additional Information: GSK Receipt Date: 14-JUL-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient had some poison ivy and a rash in the crease between belly and right hip. The patient asked whether to get the second shot while patient would be starting a prednisone taper prescription for poison ivy. Follow-up would not possible as no contact details were available.
Really bad sinus infection. Acute Bronchitis. Throat was not red but it was closing off. They had to give me injections. 2nd visit to the urgent care, they did a COVID-19 test - negative. They put me on more antibiotics.
Felt a soreness in their arms, and there may have been a "mild effect."; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Felt a soreness in their arms, and there may have been a "mild effect.") in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (Felt a soreness in their arms, and there may have been a "mild effect."). At the time of the report, PAIN IN EXTREMITY (Felt a soreness in their arms, and there may have been a "mild effect.") outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.   This case was linked to MOD-2021-363252, MOD-2021-363423.
38 year old male received first dose of AVA on 7/21/04, along with HAV and HBV vaccine. Also received PPD test in left arm. 2-3 hours later he experienced sweats (no rigors) and tender pectoral muscle. The next morning he was unable to lift his arm because of pain and went to the clinic. Large reaction at PPD site left arms (approximately 15mm redness, heat and tenderness). Subject was hospitalized to rule out cardiac problems. Recovery status unknown. Follow-up: BioPort Corp. has no further information on this case. In the event that additional relevant medical informtion is received a follow-up report will be submitted.
they put something in her gums for numbness; Can't Taste; This is a spontaneous report from a contactable consumer (Patient). A 19-years-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot Number: EW0167, Expiration Date: 31Aug2021, NDC number: Unknown), via an unspecified route of administration, administered in left arm on 06May2021 (at the age of 19-year-old) as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. There were no investigation assessment and no other products. On an unspecified date patient experienced if something they put in her gums for numbness and on 06May2021, patient experienced can't taste. The clinical course reported as follows, Caller states when she got the vaccine today they asked about any other vaccines she had recently. Caller states the only thing that slipped her mind was they put something in her gums for numbness the other day at the dentist. Caller asks if that will have an effect on the vaccine or not.   Caller states since she has gotten the shot, she can't taste. Clarifies her taste was not gone completely. States if it was on her tongue, she can't taste it but if swallows it, then she can taste it. Caller states she tested it by candy, once she swallowed, she could taste it, but when it was directly on her tongue, she couldn't taste anything. Caller states if she licks ice cream, she can't taste it at all. Caller states she read the entire fact sheet and she doesn't see anything about that and was asking was this a normal side effect from the vaccine. Caller confirms today was her first dose of the vaccine. The outcome of event can't taste was not recovered and for other it was unknown.  No follow-up attempts are needed. No further information is expected.
PATIENT CALLED MORNING AFTER AND SHE BROKE OUT IN HIVES ON HER ABDOMEN AND WAS ITCHING.  NO OTHER SYMPTOMS REPORTED BY PATIENT.  PATIENT INSRUCTED TO TAKE BENADRYL OTC.
Information has been received from a 73 years old female patient via field representative concerning herself, and the patient is a retired physician. The patient's concurrent conditions, medical history and concomitant medication were not reported. In August 2016 (reported as two Friday's ago), the patient was vaccinated with ZOSTAVAX (strength, dose, route, lot number and expiration date were unknown). In August 2016, after vaccinated the ZOSTAVAX, the patient experienced injection site red, hot and painful. The patient received treatment with hydrocortisone. The outcome of the events was unknown. The causal relationship between the events and ZOSTAVAX was unknown. Additional information has been requested.
received expired dose; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 5-month-old male patient who received HBV (Engerix B) (batch number 77BS9, expiry date 22nd September 2021) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 30th September 2021, the patient received Engerix B and Engerix B Pre-Filled Syringe Device. On 30th September 2021, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: This case was reported by the medical assistant. The age at vaccination was not reported. On 30th September 2021, the patient received a dose Engerix B pre-filled syringe which was already expired on 22nd September 2021. The reporter did not consent to follow-up.
redness spreading beyond injection site, Pt took OTC Benadryl and topical Benadryl. Symptoms improving
This case was reported by a nurse via call center representative and described the occurrence of itchy rash in a female patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, 8 days after receiving SHINGRIX, the patient experienced itchy rash and popular rash. The patient was treated with hydrocortisone. On an unknown date, the outcome of the itchy rash and popular rash were recovered/resolved. It was unknown if the reporter considered the itchy rash and popular rash to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. Eight to nine days after vaccination, the patient experienced rash on her cheeks, forehead, hairline, and both forearms. Rash was mildly itchy and popular. Rash resolved after applying Hydrocortisone cream to affected areas. The lot number or expiry date was not reported by the healthcare professional during call.
tachycardia, dizziness, diaphoresis, weakness, Temp 100.8 F,  911 called,    above symptoms  resolved by the time ambulance arrived.
Headache, Myalgia, Arthralgia, Fever, NauseaVomiting, INjection site pain, lymphadenopathy, extreme fatigue. States symptoms for bother first and second dose. Narrative:
perioral, numbness/tingling Employee reports peri-oral numbness/tingling 15 mins after vaccine administration. Employee immediately escorted to ED for airway evaluation. On arrival to ED, all VSS. No airway compromise. Given 50mg PO benadryl and 10mg PO zyrtec and then d/c'd home.
Mom began to notice in the afternoon of 4/25/00 red "blister like" bumps appearing behind ears, on neck and on trunk. More continued to appear generalized on body. Pt saw an MD on 4/26/00.
This spontaneous report was received from a registered nurse and refers to a 4 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 14-AUG-2017, the patient was vaccinated with an improperly stored VARIVAX at a dose of 0.5 (units not specified) from lot # N000683 with expiry date: 06-JAN-2019 (dose number, route, anatomical location and site of administration were not reported) for prophylaxis. Concomitant medications included a properly stored sterile diluent (manufacturer unknown). The administered dose of vaccine was stored in the temperature between 6 degrees Fahrenheit and 14 degrees Fahrenheit for 20 hours and in the temperature between 15 degrees Fahrenheit and 46 degrees Fahrenheit for 6 hours. There were no previous temperature excursions. Data logger was involved. No adverse effects were reported. No additional information was provided. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1707USA004945.
Weird rash on that arm on his forearm, on the top of the elbow and then he kind of started on the other arm and then on the legs a little bit, around his belly; His tongue looks like he has swollen taste buds or something; Itchy; This is a spontaneous report from a contactable consumer. A 45-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EL3247) intramuscular on the right arm on 21Jan2021 at a single dose for COVID-19 immunization. The patient had no medical history. Concomitant medications included supplements and vitamins. The patient got the COVID Vaccine on the 21st of January the Pfizer one and the following day he felt fine but he has this weird rash on that arm on his forearm, on the top of the elbow and then he kind of started on the other arm and then on the legs a little bit, around his belly and then his tongue looked like he has swollen taste buds or something, but he said he felt fine but the reporter don't if that's a side effect. "Should he be worried, should he go to a doctor?" Reporter stated, "Because we weren't sure what it was, he did take one Benadryl like the ones you find at the drug store and then that was it. And then I put Calamine lotion, so topically couple times just to prevent him from scratching but not regularly just when he feels really, really itchy." Outcome of the events was unknown.
suicidal thougths; Severe depression; tgen my c-ptsd got so severe; This is a spontaneous report from a Non-contactable consumer (patient). A 34-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: unknown) via an unspecified route of administration (Age at time of vaccination: 34) on 03Sep2021, 03.45 PM in left arm as dose 1, single dose for COVID-19 immunisation. Patient medical history reported as C-pstd, migraines, concussions, fibromyalgia, pmdd, endometriosis, diabetes type 2, high blood pressure from an unknown start and stop dates. Patient's known allergies were too many to list. Concomitant medication reported as Vitamin B12, folic acid, fluvoxamine, buisperone. No other vaccine administered within four weeks. COVID prior vaccination was reported as no and COVID test post vaccination reported as no. On 05Sep2021 03:30 AM, patient experienced Severe depression and suicidal thoughts increase and tgen c-ptsd got so severe. On unspecified date patient underwent lab test and procedure included Blood pressure measurement: high. Treatment was not taken. The clinical outcome of all events were unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
A rash appeared on the upper left leg about 5-10 minutes after the vaccine was administered. A slight burning/stinging sensation was experienced during the 15 minute observation period after vaccine administration; however, at the time, this was attributed to warmth from sitting in the sun. After return to work, the rash was noticed during a bathroom break, which spanned the entirety of the front of the upper left leg. A significant amount of nausea was also experienced about an hour after vaccine administration; however, it stopped short of vomiting. The rash lessened throughout the day and was nearly gone by the end of the night. The nausea also subsided around 6 pm. Only mild flu-like symptoms were experienced the following day (headache, fatigue, head congestion), which were ameliorated 48 hrs post vaccine administration. Pain in the left arm was also experienced, which peaked 24 hours after vaccine administration and subsided 48 hours after.
Given 10 mcg dose of Moderna Bivalent vaccine instead of recommended 25 mcg.
Had some very strong reactions to the first two doses of Moderna.; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION COMPLICATION (Had some very strong reactions to the first two doses of Moderna.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On an unknown date, the patient experienced VACCINATION COMPLICATION (Had some very strong reactions to the first two doses of Moderna.). At the time of the report, VACCINATION COMPLICATION (Had some very strong reactions to the first two doses of Moderna.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Treatment details were not provided.   This case was linked to MOD-2022-445722 (Patient Link).
Three (3) HPV, lot # (J013324) had been exposed to the out of range temperature and needed to be returned to facility. These three vaccines were mistakenly and in administered to three (3) patients. Whoever the staff person was who administered 3 doses of the HPV that should not been used, clicked on the new lot number (J012212) instead of the old lot # (J013324). We have been unable to identify the three patients who received the vaccines exposed to the out of range temp. I have been identify the 12 patients who administered HPV vaccine between the dates of 2/12-2/18/14 under lot number (J012212).